Evercyte: Evercyte And Collaborate On Development Of Recombinant Media Supplements

Launch of first joint product VEGF 165 for cell culture applicationsVienna and Grambach/Graz, Austria May 24, 2016Evercyte GmbH, the leading provider of immortalized human primary-like cells and VTU Technology, the globally acting protein expression expert announced today that they have entered into a collaboration agreement on the development of recombinant media supplements...